← All indications
Hyperbilirubinemia, Neonatal
Accumulation of BILIRUBIN, a breakdown product of HEME PROTEINS, in the BLOOD during the first weeks of life. This may lead to NEONATAL JAUNDICE. The excess bilirubin may exist in the unconjugated (indirect) or the conjugated (direct) form. The condition may be self-limiting (PHYSIOLOGICAL NEONATAL JAUNDICE) or pathological with toxic levels of bilirubin.
Subtype terms (1)
More specific conditions that are subtypes of Hyperbilirubinemia, Neonatal in the MeSH hierarchy.
- Jaundice, Neonatal
9 drugs (3 approved, 6 experimental)
Drugs by status
Phase 2 trials (3)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (1)
Organization Involved with Phase 2 Indications (2)
Organization Involved with Other Experimental Indications (4)